Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
Int J Infect Dis ; 97: 299-302, 2020 Aug.
Article in English | MEDLINE | ID: covidwho-597963

ABSTRACT

Severe coronavirus disease 2019 (COVID-19) is known to be associated with a heightened risk of thromboembolism. However, the risk associated with mild and moderate illness from COVID-19 is unknown, and there is no current recommendation for prophylaxis against thromboembolism in patients after hospital treatment, unless there are established thrombophilic risk factors. We report the case of a 52-year-old woman who presented with massive saddle pulmonary embolism 1 week after initial hospital discharge, which was treated successfully with thrombolysis. This case raises the question of whether extended prophylactic anticoagulation should be considered even in low-risk COVID-19 cases.


Subject(s)
Coronavirus Infections/complications , Heart Failure/drug therapy , Pneumonia, Viral/complications , Pulmonary Embolism/drug therapy , Pulmonary Heart Disease/drug therapy , Anticoagulants/therapeutic use , Betacoronavirus , Blood Coagulation , COVID-19 , Female , Heart Failure/virology , Humans , Middle Aged , Pandemics , Pulmonary Embolism/virology , Pulmonary Heart Disease/virology , Risk Factors , SARS-CoV-2 , Thrombolytic Therapy
SELECTION OF CITATIONS
SEARCH DETAIL